Drug intelligence / Profile preview

furosemide + amiloride

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Furosemide + amiloride is a **combination drug** containing the loop diuretic furosemide and the potassium-sparing diuretic amiloride. This dual therapy is used primarily for the treatment of **hypertension (high blood pressure)** and **oedema (fluid retention)**, particularly when potassium conservation is important, such as in heart failure, liver disease, or nephrotic syndrome[1][3][7][9]. - **Furosemide** acts by inhibiting the sodium-potassium-chloride cotransporter (NKCC2) in the thick ascending loop of Henle, which blocks reabsorption of sodium and chloride and promotes diuresis[5]. - **Amiloride** inhibits epithelial sodium channels (ENaC) in the distal nephron, leading to reduced sodium reabsorption and conservation of potassium[2][6][8]. The combination is designed to clear excess fluid while counteracting furosemide-induced potassium loss[1][3].

Brand names
FrumilFrumil LSAmilaxCo-amilofruse
Other names
co-amilofrusefurosemide + amiloridefrusemide + amiloride
02

Targets

NHE3 (Sodium/hydrogen exchanger 3)

Beyond the preview

Go deeper on furosemide + amiloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on furosemide + amiloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call